Search
Beigene Ltd
ONCAdd to Watchlist
315.970USD
-6.110-1.90%
Close 07-31 16:00（ET）Quotes delayed by 15 min
32.31BMarket Cap
67.69P/E TTM
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Product
1.37B
97.35%
BRUKINSA
1.04B
73.69%
Tislelizumab
190.62M
13.50%
XGEVA
84.24M
5.97%
BLINCYTO
30.48M
2.16%
Other
-1.31B
-92.66%
By RegionUSD
Name
Revenue
Proportion
United States
754.86M
53.45%
China
439.88M
31.15%
Europe
166.58M
11.79%
ROW
50.97M
3.61%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product
1.37B
97.35%
BRUKINSA
1.04B
73.69%
Tislelizumab
190.62M
13.50%
XGEVA
84.24M
5.97%
BLINCYTO
30.48M
2.16%
Other
-1.31B
-92.66%